about
Role of natural herbs in the treatment of hypertensionResistin, an Adipokine with Non-Generalized Actions on Sympathetic Nerve ActivityPrevalence and risk factors of obesity and hypertension among students at a central university in the West Bank.Obesity-induced hepatic steatosis is mediated by endoplasmic reticulum stress in the subfornical organ of the brainGlutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemiaObesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortinsObesity hypertension: the regulatory role of leptinThe associations of adipokines with selected markers of the renin-angiotensinogen-aldosterone system: the multi-ethnic study of atherosclerosis.The influence of locus control on adherence to treatment regimen among hypertensive patients.Central Pressure and Biomarker Responses to Renin Inhibition with Hydrochlorothiazide and Ramipril in Obese Hypertensives: The ATTAIN Study.Gastrointestinal intervention ameliorates high blood pressure through antagonizing overdrive of the sympathetic nerve in hypertensive patients and rats.Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial.Total and Abdominal Adiposity and Hypertension in Indigenous Women in Midwest BrazilSerum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients - pilot study.Role of substance P in renal injury during DOCA-salt hypertension.Association between hypertension and chronic arsenic exposure in drinking water: a cross-sectional study in Bangladesh.Higher leptin is associated with hypertension: the Multi-Ethnic Study of AtherosclerosisDeletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension.Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world.The role of obesity in kidney disease: recent findings and potential mechanisms.Obesity-related hypertension.Intensive blood pressure control in obese diabetic patients: clinical relevance of stroke prevention in the ACCORD trial.Managing cardiovascular risk in overweight children and adolescents.Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.[Unhealthy behavior associated with the development of high blood pressure in adolescents].Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressureReduction of leptin levels by four cardiac hormones: Implications for hypertension in obesity.Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB.Determination of early urinary renal injury markers in obese children.High-fat diet-induced hypertension and autonomic imbalance are associated with an upregulation of CART in the dorsomedial hypothalamus of mice.Alcohol consumption and the risk of stroke among hypertensive and overweight men.Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome.Altered responsiveness of the kidney to activation of the renal nerves in fat-fed rabbits.The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension.Plasma reactive carbonyl species: Potential risk factor for hypertension.Adipokine Profiling in Adult Women With Central Obesity and Hypertension.
P2860
Q24630896-F36DA9C2-D32B-49CA-9541-267BC1E304A6Q26776170-E70F8996-0D5D-42AF-AFA8-2F1F4F987DB0Q33455182-741A2480-A518-4F7A-9FE4-A25A64D117E1Q33578954-5693F405-28D7-4E4D-B625-F2E3FCFA1338Q33818203-3FFAAC48-F384-4908-8A16-3572012CDB76Q33885038-2782565B-1864-4EE2-AB60-AC24B86E1F0FQ34496907-0908A4BB-7FDC-446C-941A-54119D5E953AQ34691889-91EAABDB-00C9-47FC-A5EA-C5F918A6CF8BQ34957532-8134C7FA-7FB5-4ED8-8E96-4D5808712682Q35005395-5DD88CFF-B10A-492A-BF9B-AAC6C5C6DD9BQ35070635-7545B190-72D2-467C-A3E9-EB2D20DD46B5Q36047137-E9E5121B-2711-431C-8DFB-CA70BCA6BD84Q36050374-83581124-460B-418C-BB0D-797DECC76204Q36105680-2C4BF2CC-471E-4702-89D5-F801F4EE0600Q36439613-F2C0C626-E5D0-40DF-A142-C825149EC220Q36538686-13D94D9F-53B9-45D6-8680-6A5523707D81Q37076269-85D86370-93F9-4674-8C8F-9B34D56B0410Q37160066-8DC1CF20-52D9-49DB-A0B7-3AE9ACE0AB82Q37362687-0B8CA30A-7E78-418E-A363-580F921F02A7Q37872237-0C1E819E-F043-4E86-B063-DFE1C5619ECDQ37878315-FDFCF302-81E5-47DE-8E3F-1BB62FE97A27Q38068591-06087BAD-9036-423F-B034-8ACC72959797Q38098481-8D8F8986-B24E-4D5D-9DE0-02DAC0B0F419Q38758765-24BC81A6-8709-4193-8A38-822D05EC8E29Q40256570-89B3219E-1061-4B9C-B278-9A41DD7CAEC2Q41844127-48404368-F51F-4BE6-A66F-E4BFAB662D24Q42046319-77A48B15-4FB7-49D3-961C-8AEA6E0FD34CQ42058427-069A0A05-C7DA-46F9-8C91-B4B07EC2892DQ42220276-E3560924-53CE-40CB-A86A-5EB87B41E002Q42711721-7AFBE7DC-BCA9-40D4-9162-6606A49F205BQ45754495-D8043DF7-D2DD-419E-BEE9-D21696A0DDC1Q46703877-DB52B08D-574C-4140-A28F-3002C4AED030Q48439233-2C26BEF5-6059-4A66-95AF-90E667F02E22Q50101685-7A02E0DF-17A3-47BB-BD96-BB874E7D30DDQ51888673-2868891F-266B-41F1-8959-AA5A35F3EB5FQ55548906-EAFF1966-C195-4400-8868-C34E0074E8E9
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Pathophysiology and treatment of obesity hypertension.
@ast
Pathophysiology and treatment of obesity hypertension.
@en
Pathophysiology and treatment of obesity hypertension.
@nl
type
label
Pathophysiology and treatment of obesity hypertension.
@ast
Pathophysiology and treatment of obesity hypertension.
@en
Pathophysiology and treatment of obesity hypertension.
@nl
prefLabel
Pathophysiology and treatment of obesity hypertension.
@ast
Pathophysiology and treatment of obesity hypertension.
@en
Pathophysiology and treatment of obesity hypertension.
@nl
P356
P1476
Pathophysiology and treatment of obesity hypertension.
@en
P2093
John E Hall
Marion R Wofford
P304
P356
10.2174/1381612043382855
P577
2004-01-01T00:00:00Z